Description
Gina Columbus reports on FDA approvals in breast cancer and pediatric melanoma, disappointing results in a head and neck cancer trial, and European approval recommendations in follicular lymphoma, non–small cell lung cancer, and urothelial carcinoma.
Tags
cancer oncology